Results 81 to 90 of about 9,042 (268)

Attenuated Infectious Bronchitis Virus (IBV) Vaccination Induces Protective Humoral and Cellular Immunity Against SARS‐CoV‐2 in Mammals

open access: yesJournal of Immunology Research, Volume 2026, Issue 1, 2026.
Occupational exposure to infectious bronchitis virus (IBV) has been associated with cross‐reactivity to other coronaviruses such as SARS‐CoV‐2. In this study, we investigated the immune response of IBV using reconstituted samples of the commercial H120 Mass‐I vaccine (Zoetis) against SARS‐CoV‐2 infection.
Ney de Carvalho Almeida   +20 more
wiley   +1 more source

Explaining temporal trends in annualized relapse rates in placebo groups of randomized controlled trials in relapsing multiple sclerosis: systematic review and meta-regression

open access: yes, 2013
Background: Recent studies have shown a decrease in annualised relapse rates (ARRs) in placebo groups of randomised controlled trials (RCTs) in relapsing multiple sclerosis (RMS).
Friede, Tim   +5 more
core   +1 more source

Public Oncologic Serum Biobank [PDF]

open access: yes, 2014
The Public Oncologic Serum Biobank is a not for-profit organization that has been established within the academia setting since 2009, which aims to prospectively collect and store serum samples from cancer patients and volunteers and their associated ...
Puricelli, Lydia Ines   +1 more
core   +2 more sources

Immobilized Enzymes for ABO‐Independent Blood Cell Transfusions

open access: yesChemBioChem, Volume 26, Issue 24, December 11, 2025.
A method is developed to generate universal red blood cells and platelets using suitable glycosidases immobilized to polymethacrylate microparticles. This approach allows the efficient removal of the enzymes converting the A and B antigens before transfusion to avoid immune reactions and illustrates a promising method to counteract the demand for blood
Christina Möller   +11 more
wiley   +1 more source

Implementation of third-generation digital PCR for non-invasive prenatal diagnosis of sickle cell disease and early detection. Pilot study

open access: yesFrontiers in Medicine
Sickle cell disease (SCD) is one of the most prevalent autosomal recessive conditions worldwide, affecting more than 600,000 newborns annually. Despite advances in treatment, it remains a chronic condition requiring lifelong management.
Sara Ferrer Benito   +23 more
doaj   +1 more source

The association of germline variants with chronic lymphocytic leukemia outcome suggests the implication of novel genes and pathways in clinical evolution

open access: yesBMC Cancer, 2019
Background Chronic Lymphocytic Leukemia (CLL) is the most frequent lymphoproliferative disorder in western countries and is characterized by a remarkable clinical heterogeneity. During the last decade, multiple genomic studies have identified a myriad of
Adrián Mosquera Orgueira   +9 more
doaj   +1 more source

Enrichment of iron and folic acid: the real need and the dangers of this initiative [PDF]

open access: yes, 2011
Universidade Federal de São Paulo (UNIFESP) Pediatric DepartmentUniversidade Federal de São Paulo (UNIFESP)UNIFESP, Pediatric ...
Fisberg, Mauro   +1 more
core   +2 more sources

Monitoring of BCR-ABL levels in chronic myeloid leukemia patients treated with imatinib in the chronic phase: the importance of a major molecular response [PDF]

open access: yes, 2011
BACKGROUND: Real time PCR has become the most common technique to monitor BCR-ABL transcript levels of patients treated with kinase inhibitors. The aim of this study was to evaluate BCR-ABL levels of chronic myeloid leukemia patients treated with ...
BENDIT, Israel   +8 more
core   +2 more sources

Hemostasis and Hemotherapy [PDF]

open access: yesTransfusion Medicine and Hemotherapy, 2017
W. Korte, M. Cattaneo
openaire   +2 more sources

Letter: Using Anti‐HBs Titers to Tailor HBV Reactivation Monitoring in Patients With Solid Tumours—Authors' Reply

open access: yes
Alimentary Pharmacology &Therapeutics, Volume 63, Issue 5, Page 768-769, March 2026.
Hans L. Tillmann   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy